Mezoxia 160 mg
(Megestrol Acetate Tablets USP)
Manufactured by: Everest Pharmaceuticals
Distributed by: NP Molecule
Strength: 160 mg
Packaging: 30 Tablets per Bottle
Contact: +8801844288466 | npmolecule23@gmail.com
π www.npmoleculeoncology.com
π¬ Product Overview
Mezoxia 160 mg contains Megestrol Acetate, a synthetic derivative of the hormone progesterone. It is commonly used in the treatment of hormone-responsive cancers and as an appetite stimulant in certain chronic conditions.
π Indications
-
Cancer Treatment:
-
Appetite Stimulant / Cachexia Management:
π§ͺ Mechanism of Action
Megestrol Acetate acts by:
-
Inhibiting the pituitary gonadotropin production
-
Exerting direct anti-tumor activity on hormone-sensitive cancer cells
-
Promoting weight gain and appetite stimulation through interaction with glucocorticoid receptors
π Dosage & Administration
-
Usual Dose: 160 mg to 800 mg per day (based on condition and patient response)
-
Form: Oral, once or twice daily
-
Duration: Determined by physician based on clinical condition
β οΈ Precautions & Warnings
-
Use in Pregnancy: Not recommended (Category D)
-
Thromboembolic Disorders: Use with caution in patients at risk
-
Diabetes: May cause alterations in glucose control
-
Adrenal Suppression: Long-term use may affect adrenal function
π Common Side Effects
π¦ Storage Instructions
-
Store at room temperature (below 30Β°C)
-
Protect from moisture and direct light
-
Keep out of reach of children
π Product Classification
Category | Description |
---|
Pharmaceutical | Hormonal Agent / Antineoplastic |
Therapeutic Class | Progestin / Appetite Stimulant |
Indication-Based | Oncology / Cachexia Management |
Drug Form | Oral Tablet |